Erratum: Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma (Oncogene (2005) 24 (4442-4449) DOI:10.1038/sj.onc.1208635);Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma

Oncogene

Volumn 24, Issue 27, 2005, Pages 4442-4449

  Lai, Stephen Y ^a   Childs, Erin E ^a   Xi, Sichuan ^a   Coppelli, Francesca M ^a   Gooding, William E ^b   Wells, Alan ^b   Ferris, Robert L ^a,b   Grandis, Jennifer R ^a,b  

^a University of Pittsburgh School of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Erythropoietin; Erythropoietin receptor; Head and neck cancer; HNSCC; Invasion; JAK STAT

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE; STAT PROTEIN; DNA BINDING PROTEIN; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; MILK PROTEIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN; TYRPHOSTIN; TYRPHOSTIN AG-490;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; CANCER INVASION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; TUMOR CELL LINE;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ERYTHROPOIETIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MILK PROTEINS; MUTATION; NEOPLASM INVASIVENESS; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYRPHOSTINS;

EID: 21744451644     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209224     Document Type: Erratum

References (46)

1. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K and Verma A. (2001). Cancer Res., 61, 3561-3565.
2. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H and Verma A. (2003). Am. J. Pathol., 162, 1789-1806.
3. Acs G, Zhang PJ, Rebbeck TR, Acs P and Verma A. (2002). Cancer, 95, 969-981.
4. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN. (1987). Cancer Res., 47, 3239-3245.
5. Arcasoy M, Amin K, Chou SC, Haroon ZA, Varia M and Raleigh JA. (2005). Clin. Cancer Res., 11, 20-27.
6. Arcasoy M, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA and Haroon ZA. (2002). Lab. Invest., 82, 911-918.
7. BEST Investigators and Study Group (2003). Lancet Oncol., 4, 459-460.
8. Boucheron C, Dumon S, Santos SC, Moriggl R, Hennighausen L, Gisselbrecht S and Gouilleux F. (1998). J. Biol. Chem., 273, 33936-33941.
9. Chu YW, Runyan RB, Oshima RG and Hendrix MJ. (1993). Proc. Natl. Acad. Sci. USA, 90, 4261-4265.
10. David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC and Johnson GR. (1996). J. Biol. Chem., 271, 9185-9188.
11. Gall R and Kerr PD. (2000). J. Otolaryngol., 29, 131-134.
12. Glaser C, Millesi W, Kornek GV, Lang S, Schull B, Watzinger F, Selzer E and Lavey RS. (2001). Int. J. Radiat. Oncol. Biol. Phys., 50, 705-715.
13. Godfrey TE, Kim S-H, Chavira M, Ruff DW, Warren RS, Gray JW and Jensen RH. (2000). J. Mol. Diagn., 2, 84-91.
14. Grandis J, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy DJ. (1998). J. Clin. Invest., 102, 1385-1392.
15. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG and Morrow M (eds). 2002. AJCC Cancer Staging Manual, 6th edn. Springer-Verlag: New York.
16. Guo Y, Mascareno E and Siddiqui MA. (2004). Mol. Endocrinol., 18, 1033-1041.
17. Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C and Frommhold H. (2003). Lancet, 362, 1255-1260.
18. Heo D, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB and Whiteside TL. (1989). Cancer Res., 49, 5167-5175.
19. Hwa V, Little B, Kofoed EM and Rosenfeld RG. (2004). J. Biol. Chem., 279, 2728-2736.
20. Ihle J, Witthuhn BA, Quelle FW, Yamamoto K and Silvennoinen O. (1995). Annu. Rev. Immunol., 13, 369-398.
21. Jelkmann W. (1994). Clin. Invest., 72, S3-S10.
22. Jemal A, Thomas A, Murray T and Thom M. (2002). CA Cancer J. Clin., 52, 23-47.
23. Lacombe C and Mayeux P. (1999). Transplant, 14, 22-28.
24. Leong P, Xi S, Drenning SD, Dyer KF, Wentzel AL, Lerner EC, Smithgall TE and Grandis JR. (2002). Oncogene, 21, 2846-2853.
25. Littlewood T, Bajetta E, Nortier JW, Vercammen E, Rapoport B and Epoetin Alfa Study Group. (2001). J. Clin. Oncol., 19, 2865-2874.
26. Liu K, Gaffen SL and Goldsmith MA. (1998). Curr. Opin. Immunol., 10, 271-278.
27. Liu W, Powles T, Shamash J, Propper D, Oliver T and Joel S. (2004). Oncogene, 23, 981-990.
28. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A and Hennighausen L. (1997). Genes Dev., 11, 179-186.
29. Meinke A, Barahmand-Pour F, Wohrl S, Stoiber D and Decker T. (1996). Mol. Cell. Biol., 16, 6937-6944.
30. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A and Roifman CM. (1996). Nature, 379, 645-648.
31. Opdam F, Kamp M, de Bruijn R and Roos E. (2004). Oncogene, 23, 6647-6653.
32. Pajonk F, Weil A, Sommer A, Suwinski R and Henke M. (2004). Oncogene, 23, 8987-8991.
33. Sacks P, Parnes SM, Gallick GE, Mansouri Z, Lichtner R, Satya-Prakash KL, Pathak S and Parsons DF. (1988). Cancer Res., 48, 2858-2866.
34. Shasha D. (2001). Semin. Hematol., 38, 8-15.
35. Tabbara I. (1993). Arch. Intern. Med., 153, 298-304.
36. Thatcher N. (1998). Semin. Oncol., 25, 23-26.
37. Thomas S, Copelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD and Grandis JR. (2003). Cancer Res., 63, 5629-5635.
38. Udy G, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ and Davey HW. (1997). Proc. Natl. Acad. Sci. USA, 94, 7239-7244.
39. Virolainen E, Carey TE, Wicha M and Krause CJ. (1983). Oto-HNS, 91, 126-135.
40. Wojchowski D, Gregory RC, Miller CP, Pandit AK and Pircher TJ. (1999). Exp. Cell Res., 253, 143-156.
41. Xi S, Zhang Q, Gooding WE, Smithgall TE and Grandis JR. (2003). Cancer Res., 63, 6763-6771.
42. Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A, Onozaki M, Hashimoto M, Musha T, Ogawa K, Fujita H, Nakamura Y, Shiozaki H and Utsumi H. (2003). Carcinogenesis, 24, 1021-1029.
43. Yasuda Y, Masuda S, Chikuma M, Inoue K, Nagao M and Sasaki R. (1998). J. Biol. Chem., 273, 25381-25387.
44. Yokomizo R, Matsuzaki S, Uehara S, Murakami T, Yaegashi N and Okamura K. (2002). Mol. Hum. Reprod., 8, 441-446.
45. Yoshimura A, Longmore G and Lodish HF. (1990). Nature, 348, 647-649.
46. Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ and Broxmeyer HE. (2000). J. Eukaryot Microbiol, 192, 719-728.